|
ABVD is a chemotherapy regimen used in the first-line treatment of Hodgkin lymphoma, supplanting the older MOPP protocol. It consists of concurrent treatment with the chemotherapy drugs: *(A)driamycin (also known as doxorubicin/(H)ydroxydaunorubicin, designated as H in CHOP) *(B)leomycin *(V)inblastine *(D)acarbazine (similar to (P)rocarbazine, designated as P in MOPP and in COPP) ==Indications== As of 2007, ABVD is widely used as the initial chemotherapy treatment for newly diagnosed Hodgkin's lymphoma . The other chemotherapy regimen that is widely used in this setting is the Stanford V regimen. 抄文引用元・出典: フリー百科事典『 ウィキペディア(Wikipedia)』 ■ウィキペディアで「ABVD」の詳細全文を読む スポンサード リンク
|